# 2026-12903: FDA Eases Rules for Breast Implant Retrieval System

2026-12903, Medical Devices; General and Plastic Surgery Devices; Classification of the Breast Implant Suction Retrieval System, is a Federal Register rule from Health and Human Services Department, Food and Drug Administration published 2026-06-26, effective 2026-06-26; PRIA reads it as touching household money (as of 2026-07-03).

- Canonical: https://policyrisk.com/federal-register/2026-12903
- As of: 2026-07-03
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-12903
- Title: Medical Devices; General and Plastic Surgery Devices; Classification of the Breast Implant Suction Retrieval System
- Type: Rule
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 38502
- Published: 2026-06-26
- Effective: 2026-06-26
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-07-03

## In one line

FDA Eases Rules for Breast Implant Retrieval System

## Summary

The FDA has officially placed the breast implant suction retrieval system into Class II, meaning it now has special safety rules but fewer regulatory hurdles. This change helps make the device safer and easier to get to patients without unnecessary delays. The new classification took effect on June 26, 2026, and could speed up innovation while keeping costs in check for makers and users.

## Abstract

The Food and Drug Administration (FDA) is classifying the breast implant suction retrieval system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the breast implant suction retrieval system. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

## Effects PRIA read

- Device moved to Class II — safer, more accessible: benefit, medium. The FDA officially classified the breast implant suction retrieval system as Class II (special controls), effective June 26, 2026, with the classification applicable April 20, 2023. FDA says this classification provides reasonable assurance of safety and will enhance patients' access to beneficial…
- Manufacturers must meet named special controls: cost, medium. Manufacturers of this prescription surgical device must meet specific special controls, including animal performance testing (showing removal of specified implant sizes and tissue healing assessment), non‑clinical performance testing (characterizing vacuum suction ranges, durability, and control/va…
- De Novo decision enables future 510(k) pathways: benefit, medium. Because FDA classified the device via the De Novo process, the breast implant suction retrieval system can serve as a predicate for future devices of that type, allowing other sponsors to use the less‑burdensome 510(k) pathway rather than De Novo or PMA. FDA notes De Novo classification decisions a…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-12903 on federalregister.gov](https://www.federalregister.gov/documents/2026/06/26/2026-12903/medical-devices-general-and-plastic-surgery-devices-classification-of-the-breast-implant-suction)
- [2026-12903 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-06-26/pdf/2026-12903.pdf)

## Related
- [Previous: 2026-12902, Medical Devices; Immunology and Microbiology Devices; Classification of the SAR…](https://policyrisk.com/federal-register/2026-12902)
- [Next: 2026-12904, Medical Devices; Neurological Devices; Classification of the External Lower Ext…](https://policyrisk.com/federal-register/2026-12904)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-12903 (as of 2026-07-03).